Clinical trial

Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)

NCT00116298

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-01-01

PhasePHASE3

Study timeline

Study start (unknown)2001-01-01Date precision: month

Registry last updated2011-04-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

AIDSunresolved

Interventions

stavudine, efavirenz, lamivudineDRUG

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

New YorkNew York, United States1 HoustonTexas, United States1 Los AngelesCalifornia, United States1 DallasTexas, United States1 TorontoOntario, Canada1 MadridSpain1 BarcelonaSpain1 ParisFrance1 TampaFlorida, United States1 MontrealQuebec, Canada1 Washington D.C.District of Columbia, United States1 IndianapolisIndiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00116298 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.